Navigation Links
$1.5 million NCI Grant to aid Huntsman Cancer Institute researcher study melanoma, sun damage link
Date:9/30/2013

SALT LAKE CITY -- The National Cancer Institute (NCI) has awarded Huntsman Cancer Institute investigator Matt VanBrocklin, Ph.D., more than $1.5 million over the next five years to continue studying the role of a gene called c-KIT in the origin and growth of melanoma, a devastating and sometimes deadly skin cancer. VanBrocklin is an assistant professor in the Department of Surgery at the University of Utah.

The majority of melanomas have mutations in a gene called BRAF. Mutations in c-KIT have already been identified as the most common cancer-causing event in certain melanoma subtypes that rarely harbor BRAF mutations, including a type of melanoma caused by chronic sun damage. Some clinical trials involving drugs that inhibit c-KIT's action showed good early responses, but tumors soon developed resistance to the drugs.

"Moving forward with melanoma treatments that focus on inhibiting c-KIT will require more research with animal models that faithfully mimic the human disease," said VanBrocklin. "We need to discover more details about how c-KIT works in melanoma tumors and what other genetic factors may be interacting with it as the cancer progresses and spreads to other parts of the body."

VanBrocklin has developed a novel melanoma mouse model that will allow deeper examination of c-KIT's role in melanoma's initiation and progression in living systems. The funding will allow VanBrocklin to continue studies using this mouse model to test whether active c-KIT can initiate melanoma. The research will also examine other genetic factors that could enhance c-KIT's action. The overall goal is to develop new, more effective treatments for patients whose melanoma tumors have c-KIT mutations.


'/>"/>

Contact: Linda Aagard
801-587-7639
University of Utah Health Sciences
Source:Eurekalert

Page: 1

Related biology news :

1. NOAA launches website holding millions of chemical analyses from Deepwater Horizon oil spill
2. CSHL is part of iPlant group awarded $50 million to create US biology cyberinfrastructure
3. UNLV, Sen. Reid Announce $20 Million NIH grant to support clinical health research
4. $50 million NSF grant to advance cyberinfrastructure for big data in life sciences
5. Current pledges put over 600 million people at risk of higher water scarcity
6. Wistar receives $1.5 million Department of Defense grant to ready prostate drug for clinical use
7. Field Museum to receive federal grant for unlocking 350 million years of biodiversity
8. UCLA scientists receive $2 million grant to improve quality of donor livers for transplant
9. BIDMC cardiovascular institute researchers will lead $4 million NIH grant to study micrornas
10. NIMBioS wins $18 million renewal award from National Science Foundation
11. BrightFocus Foundation announces $7.2 million in grants for Alzheimers and vision disease research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... ... 23, 2016 , ... Charm Sciences, Inc. is pleased to ... AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of the ... Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably ...
Breaking Biology Technology: